» Articles » PMID: 12086876

Small GTPases and Tyrosine Kinases Coregulate a Molecular Switch in the Phosphoinositide 3-kinase Regulatory Subunit

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2002 Jun 28
PMID 12086876
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphoinositide 3-kinase (PI3K) type IA is a heterodimer of a catalytic subunit, p110, and a regulatory subunit, p85. Here we show that p85 contains a GTPase-responsive domain and an inhibitory domain, which together form a molecular switch that regulates PI3K. H-Ras and Rac1 activate PI3K by targeting the GTPase-responsive domain. The stimulatory effect of these molecules, however, is blocked by the inhibitory domain, which functions by binding to tyrosine-phosphorylated molecules and is neutralized by tyrosine phosphorylation. The complementary effects of tyrosine kinases and small GTPases on the p85 molecular switch result in synergy between these two classes of molecules toward the activation of the PI3K/Akt pathway.

Citing Articles

PI3K Mutation Profiles on Exons 9 (E545K and E542K) and 20 (H1047R) in Mexican Patients With HER-2 Overexpressed Breast Cancer and Its Relevance on Clinical-Pathological and Survival Biological Effects.

Nieto-Coronel T, Alette O, Yacab R, Fernandez-Figueroa E, Lopez-Camarillo C, Marchat L Int J Breast Cancer. 2024; 2024:9058033.

PMID: 39444377 PMC: 11496583. DOI: 10.1155/2024/9058033.


Loss of ZBED6 Protects Against Sepsis-Induced Muscle Atrophy by Upregulating DOCK3-Mediated RAC1/PI3K/AKT Signaling Pathway in Pigs.

Liu H, Pan D, Li P, Wang D, Xia B, Zhang R Adv Sci (Weinh). 2023; 10(29):e2302298.

PMID: 37551034 PMC: 10582467. DOI: 10.1002/advs.202302298.


Natural STAT3 Inhibitors for Cancer Treatment: A Comprehensive Literature Review.

Zarezadeh S, Sharafi A, Erabi G, Tabashiri A, Teymouri N, Mehrabi H Recent Pat Anticancer Drug Discov. 2023; 19(4):403-502.

PMID: 37534488 DOI: 10.2174/1574892818666230803100554.


The potential mechanism of Neu5Gc inducing colorectal cancer based on network pharmacology and experimental validation.

Zhang L, Liu Y, La X, Yan S, Chen Y, Liang J Naunyn Schmiedebergs Arch Pharmacol. 2022; 396(4):705-718.

PMID: 36456746 DOI: 10.1007/s00210-022-02345-w.


Ras Multimers on the Membrane: Many Ways for a Heart-to-Heart Conversation.

Ozdemir E, Koester A, Nan X Genes (Basel). 2022; 13(2).

PMID: 35205266 PMC: 8872464. DOI: 10.3390/genes13020219.